These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 15550443

  • 1. Role of the endocannabinoid system in the development of tolerance to alcohol.
    Basavarajappa BS, Hungund BL.
    Alcohol Alcohol; 2005; 40(1):15-24. PubMed ID: 15550443
    [Abstract] [Full Text] [Related]

  • 2. Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence.
    Hungund BL, Basavarajappa BS.
    Alcohol Alcohol; 2000; 35(2):126-33. PubMed ID: 10787386
    [Abstract] [Full Text] [Related]

  • 3. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
    Basavarajappa BS, Hungund BL.
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
    [Abstract] [Full Text] [Related]

  • 4. Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.
    Hungund BL, Basavarajappa BS.
    Ann N Y Acad Sci; 2004 Oct; 1025():515-27. PubMed ID: 15542757
    [Abstract] [Full Text] [Related]

  • 5. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW, Thorpe AJ, Schlosburg JE, Cravatt BF, Abdullah RA, Smith TH, Selley DE, Lichtman AH, Sim-Selley LJ.
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [Abstract] [Full Text] [Related]

  • 6. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR.
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [Abstract] [Full Text] [Related]

  • 7. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M.
    Alcohol Alcohol; 2005 Dec; 40(1):2-14. PubMed ID: 15550444
    [Abstract] [Full Text] [Related]

  • 8. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S, Fernández-Ruiz J, Di Marzo V, Hernández M, Arévalo C, Nicanor C, Cascio MG, Ambrosio E, Ramos JA.
    Drug Alcohol Depend; 2004 May 10; 74(2):159-70. PubMed ID: 15099659
    [Abstract] [Full Text] [Related]

  • 9. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.
    González S, Cascio MG, Fernández-Ruiz J, Fezza F, Di Marzo V, Ramos JA.
    Brain Res; 2002 Nov 01; 954(1):73-81. PubMed ID: 12393235
    [Abstract] [Full Text] [Related]

  • 10. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L, Di Marzo V.
    Best Pract Res Clin Endocrinol Metab; 2009 Feb 01; 23(1):1-15. PubMed ID: 19285257
    [Abstract] [Full Text] [Related]

  • 11. Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse.
    González S, Valenti M, de Miguel R, Fezza F, Fernández-Ruiz J, Di Marzo V, Ramos JA.
    Br J Pharmacol; 2004 Oct 01; 143(4):455-64. PubMed ID: 15371286
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
    Laine K, Järvinen K, Mechoulam R, Breuer A, Järvinen T.
    Invest Ophthalmol Vis Sci; 2002 Oct 01; 43(10):3216-22. PubMed ID: 12356827
    [Abstract] [Full Text] [Related]

  • 13. The endocannabinoid system in neurodegeneration.
    Battista N, Fezza F, Finazzi-Agrò A, Maccarrone M.
    Ital J Biochem; 2006 Oct 01; 55(3-4):283-9. PubMed ID: 17274532
    [Abstract] [Full Text] [Related]

  • 14. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
    Maccarrone M, Finazzi-Agró A.
    Cell Death Differ; 2003 Sep 01; 10(9):946-55. PubMed ID: 12934069
    [Abstract] [Full Text] [Related]

  • 15. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.
    González S, Bisogno T, Wenger T, Manzanares J, Milone A, Berrendero F, Di Marzo V, Ramos JA, Fernández-Ruiz JJ.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):260-6. PubMed ID: 10733937
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The endogenous cannabinoid system and the treatment of marijuana dependence.
    Piomelli D.
    Neuropharmacology; 2004 Apr 02; 47 Suppl 1():359-67. PubMed ID: 15464150
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.